FR2753374A1 - Skin care composition contains peroxidised fatty substance e.g. unsaturated vegetable oils and plant extract - Google Patents
Skin care composition contains peroxidised fatty substance e.g. unsaturated vegetable oils and plant extract Download PDFInfo
- Publication number
- FR2753374A1 FR2753374A1 FR9611438A FR9611438A FR2753374A1 FR 2753374 A1 FR2753374 A1 FR 2753374A1 FR 9611438 A FR9611438 A FR 9611438A FR 9611438 A FR9611438 A FR 9611438A FR 2753374 A1 FR2753374 A1 FR 2753374A1
- Authority
- FR
- France
- Prior art keywords
- cosmetic composition
- composition according
- oil
- plant
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 239000000126 substance Substances 0.000 title claims abstract description 21
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 4
- 239000008158 vegetable oil Substances 0.000 title claims abstract description 4
- 239000000419 plant extract Substances 0.000 title claims description 18
- 241000196324 Embryophyta Species 0.000 claims abstract description 35
- 239000002537 cosmetic Substances 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 20
- 239000003921 oil Substances 0.000 claims abstract description 20
- 235000019198 oils Nutrition 0.000 claims abstract description 20
- 239000000839 emulsion Substances 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 230000035876 healing Effects 0.000 claims abstract description 8
- 239000006071 cream Substances 0.000 claims abstract description 7
- 229930195732 phytohormone Natural products 0.000 claims abstract description 7
- 239000000341 volatile oil Substances 0.000 claims abstract description 7
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 6
- 230000001172 regenerating effect Effects 0.000 claims abstract description 6
- 229930182490 saponin Natural products 0.000 claims abstract description 6
- 150000007949 saponins Chemical class 0.000 claims abstract description 6
- 235000013311 vegetables Nutrition 0.000 claims abstract description 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 5
- 235000005687 corn oil Nutrition 0.000 claims abstract description 5
- 239000003599 detergent Substances 0.000 claims abstract description 5
- 238000005502 peroxidation Methods 0.000 claims abstract description 5
- 230000005855 radiation Effects 0.000 claims abstract description 5
- 235000016622 Filipendula ulmaria Nutrition 0.000 claims abstract description 4
- 244000061544 Filipendula vulgaris Species 0.000 claims abstract description 4
- 235000008694 Humulus lupulus Nutrition 0.000 claims abstract description 4
- 235000010582 Pisum sativum Nutrition 0.000 claims abstract description 4
- 240000004713 Pisum sativum Species 0.000 claims abstract description 4
- 240000001890 Ribes hudsonianum Species 0.000 claims abstract description 4
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims abstract description 4
- 235000001466 Ribes nigrum Nutrition 0.000 claims abstract description 4
- 239000008168 almond oil Substances 0.000 claims abstract description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 4
- 241000157282 Aesculus Species 0.000 claims abstract description 3
- 244000208874 Althaea officinalis Species 0.000 claims abstract description 3
- 235000006576 Althaea officinalis Nutrition 0.000 claims abstract description 3
- 240000005528 Arctium lappa Species 0.000 claims abstract description 3
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 3
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 3
- 244000004281 Eucalyptus maculata Species 0.000 claims abstract description 3
- 241000195480 Fucus Species 0.000 claims abstract description 3
- 241000208680 Hamamelis mollis Species 0.000 claims abstract description 3
- 241000207963 Harpagophytum Species 0.000 claims abstract description 3
- 229920000715 Mucilage Polymers 0.000 claims abstract description 3
- 235000012544 Viola sororia Nutrition 0.000 claims abstract description 3
- 241001106476 Violaceae Species 0.000 claims abstract description 3
- 239000000853 adhesive Substances 0.000 claims abstract description 3
- 229940106189 ceramide Drugs 0.000 claims abstract description 3
- 150000001783 ceramides Chemical class 0.000 claims abstract description 3
- 235000013339 cereals Nutrition 0.000 claims abstract description 3
- 230000029087 digestion Effects 0.000 claims abstract description 3
- 239000006185 dispersion Substances 0.000 claims abstract description 3
- 239000012530 fluid Substances 0.000 claims abstract description 3
- 235000010181 horse chestnut Nutrition 0.000 claims abstract description 3
- 238000001802 infusion Methods 0.000 claims abstract description 3
- 230000000977 initiatory effect Effects 0.000 claims abstract description 3
- 238000002386 leaching Methods 0.000 claims abstract description 3
- 238000002803 maceration Methods 0.000 claims abstract description 3
- 235000001035 marshmallow Nutrition 0.000 claims abstract description 3
- 239000004006 olive oil Substances 0.000 claims abstract description 3
- 235000008390 olive oil Nutrition 0.000 claims abstract description 3
- 238000003825 pressing Methods 0.000 claims abstract description 3
- 235000002020 sage Nutrition 0.000 claims abstract description 3
- 239000010497 wheat germ oil Substances 0.000 claims abstract description 3
- 229940118846 witch hazel Drugs 0.000 claims abstract description 3
- 235000017709 saponins Nutrition 0.000 claims abstract 4
- 241000086254 Arnica montana Species 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims description 12
- 240000000731 Fagus sylvatica Species 0.000 claims description 4
- 235000010099 Fagus sylvatica Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 235000008935 nutritious Nutrition 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 2
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 2
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 2
- 244000105624 Arachis hypogaea Species 0.000 claims description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 2
- 235000018262 Arachis monticola Nutrition 0.000 claims description 2
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 claims description 2
- 235000007689 Borago officinalis Nutrition 0.000 claims description 2
- 240000004355 Borago officinalis Species 0.000 claims description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 2
- 244000020551 Helianthus annuus Species 0.000 claims description 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 claims description 2
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 claims description 2
- 235000010703 Modiola caroliniana Nutrition 0.000 claims description 2
- 244000038561 Modiola caroliniana Species 0.000 claims description 2
- 241000219925 Oenothera Species 0.000 claims description 2
- 235000004496 Oenothera biennis Nutrition 0.000 claims description 2
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 2
- 244000000231 Sesamum indicum Species 0.000 claims description 2
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 2
- 244000003892 Vaccinium erythrocarpum Species 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 239000010775 animal oil Substances 0.000 claims description 2
- 238000004061 bleaching Methods 0.000 claims description 2
- 230000001914 calming effect Effects 0.000 claims description 2
- 238000004040 coloring Methods 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 239000004571 lime Substances 0.000 claims description 2
- 235000020232 peanut Nutrition 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 241000736851 Tagetes Species 0.000 claims 1
- 235000012308 Tagetes Nutrition 0.000 claims 1
- 230000002745 absorbent Effects 0.000 claims 1
- 239000002250 absorbent Substances 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
- 235000005881 Calendula officinalis Nutrition 0.000 abstract description 2
- 235000019483 Peanut oil Nutrition 0.000 abstract description 2
- 235000019486 Sunflower oil Nutrition 0.000 abstract description 2
- 240000000785 Tagetes erecta Species 0.000 abstract description 2
- 239000000312 peanut oil Substances 0.000 abstract description 2
- 239000002600 sunflower oil Substances 0.000 abstract description 2
- 235000019489 Almond oil Nutrition 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 244000139693 Arctostaphylos uva ursi Species 0.000 abstract 1
- 240000000982 Malva neglecta Species 0.000 abstract 1
- 235000000060 Malva neglecta Nutrition 0.000 abstract 1
- 240000008916 Oenothera biennis Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 240000007313 Tilia cordata Species 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 230000005250 beta ray Effects 0.000 abstract 1
- 229940094199 black currant oil Drugs 0.000 abstract 1
- 235000021324 borage oil Nutrition 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 229940089020 evening primrose oil Drugs 0.000 abstract 1
- 239000010475 evening primrose oil Substances 0.000 abstract 1
- 239000003925 fat Substances 0.000 abstract 1
- 229940013317 fish oils Drugs 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 239000008159 sesame oil Substances 0.000 abstract 1
- 235000011803 sesame oil Nutrition 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 150000003180 prostaglandins Chemical class 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 241000208983 Arnica Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 101000862089 Clarkia lewisii Glucose-6-phosphate isomerase, cytosolic 1A Proteins 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010473 blackcurrant seed oil Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 150000003595 thromboxanes Chemical class 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/38—Percompounds, e.g. peracids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
L'invention concerne une composition cosmétique comportant au moins un extrait végétal actif associé à des huiles végétales peroxydées destinée à préserver et à améliorer l'état de la peau. The invention relates to a cosmetic composition comprising at least one active plant extract associated with peroxidized vegetable oils intended to preserve and improve the condition of the skin.
Depuis toujours, l'homme extrait du végétal des actifs pour se nourrir, s'embellir, se soigner. Historically, humans have extracted active ingredients from plants to nourish themselves, enhance their beauty and heal themselves.
Par ailleurs, les applications pour la peau de produits comprenant des corps gras peroxydés sont connues depuis longtemps. Dans les années 1950 le Professeur BARANGER, reprenant des traditions millénaires, a confirmé ces dernières et décrit l'intérêt des huiles peroxydées il en a réglé l'obtention, et a trouvé de nombreuses applications utiles à la peau. I1 a imaginé des possibilités d'applications plus lourdes dans le domaine médical. Furthermore, the applications for the skin of products comprising peroxidized fatty substances have been known for a long time. In the 1950s, Professor BARANGER, taking up millennial traditions, confirmed these and described the interest of peroxidized oils, he regulated their production, and found many applications useful for the skin. He imagined possibilities of heavier applications in the medical field.
L'invention consiste à combiner dans une même composition cosmétique les propriétés respectives des corps gras peroxydés et des actifs végétaux en quantité comprise entre 1 et 20%. The invention consists in combining in the same cosmetic composition the respective properties of peroxidized fatty substances and plant active ingredients in an amount between 1 and 20%.
I1 a été observé, dans la plupart des cas, que pour le domaine de la peau, l'effet obtenu est surprenant car sensiblement plus important que celui attendu consistant en l'addition des effets des deux composants appliqués indépendamment. It has been observed, in most cases, that for the skin area, the effect obtained is surprising since it is significantly greater than that expected consisting of the addition of the effects of the two components applied independently.
Cette propriété de potentialisation ou de synergie de cette combinaison pourrait s'expliquer par une diminution de l'inflammation et simultanément par une augmentation du flux sanguin sous cutané par l'effet du corps gras peroxydé, permettant ainsi une action plus forte et plus rapide de la drogue végétale.  This potentiating or synergistic property of this combination could be explained by a decrease in inflammation and simultaneously by an increase in subcutaneous blood flow by the effect of the peroxidized fatty substance, thus allowing a stronger and faster action of vegetable drugs.
Dans le processus inflammatoire, l'acide arachidonique, constituant des membranes cellulaires, subit une peroxydation par le biais des Ciclooxygénases et des
Lipoxygénases. Il y a alors formation des Prostaglandines et des Leucotriènes, dérivés qui vont agir au niveau des récepteurs des polynucléaires neutrophiles et macrophages en les stimulant et favorisant ainsi la réaction inflammatoire.In the inflammatory process, arachidonic acid, constituting cell membranes, undergoes peroxidation through Ciclooxygenases and
Lipoxygenases. There is then the formation of prostaglandins and leukotrienes, derivatives which will act at the level of the receptors of the neutrophils and macrophages by stimulating them and thus promoting the inflammatory reaction.
L'huile hyperoxygénée (riche en C18 et C20) agit par analogie structurale avec les dérivées de l'acide arachidonique. Ces triglycérides peroxygénés se substituent aux Prostaglandines et Leucotriènes au niveau de leurs récepteurs, sur les macrophages et polynucléaires bloquant ainsi le processus inflammatoire. The hyperoxygenated oil (rich in C18 and C20) acts by structural analogy with derivatives of arachidonic acid. These peroxygenated triglycerides replace Prostaglandins and Leukotrienes at their receptors, on macrophages and polynuclear thus blocking the inflammatory process.
Il y a également un pouvoir inhibiteur sur la production de Thromboxanes et de ce fait une augmentation de la libération de Prostaglandine PGI2 en équilibre permanent avec le Thromboxane A2. Cette Prostaglandine possède un puissant pouvoir vasodilatateur qui est alors mis à profit au niveau de la microcirculation. There is also an inhibitory power on the production of Thromboxanes and therefore an increase in the release of Prostaglandin PGI2 in permanent equilibrium with Thromboxane A2. This prostaglandin has a powerful vasodilator power which is then used to the level of microcirculation.
Cette vasodilatation des vaisseaux sanguins dermiques a pour effet d'une part d'activer l'assise basale formée par des kératinocytes de l'épiderme provoquant une augmentation du renouvellement cellulaire de l'épiderme, et une assimilation plus rapide de l'actif ou drogue végétale favorisant ainsi sa cinétique d'action et lui permettant de répondre également au métabolisme accru des cellules stimulées par le biais de l'huile peroxygénée. This vasodilation of the dermal blood vessels has the effect on the one hand of activating the basal base formed by keratinocytes of the epidermis causing an increase in the cellular renewal of the epidermis, and a more rapid assimilation of the active or drug vegetable thus promoting its kinetics of action and allowing it to also respond to the increased metabolism of cells stimulated through peroxygenated oil.
Dans une réalisation de la combinaison selon l'invention, le ou les corps gras peroxydés sont choisis dans le groupe de ceux qui, soumis à un rayonnement x, gamma et béta, pendant au moins la phase d'initiation de la réaction, comprennent un taux de MDA ou malmaldehyde inférieur à 50 ppm. Les corps gras employés sont plus particulièrement des huiles. Ces huiles sont pour la plupart végétales. I1 s'agit en général de corps choisis dans le groupe des corps gras éthyléniques de l'huile d'olive, d'arachide, de sésame, de maïs, de tournesol, auquel on rajoute l'huile d'amande douce, ainsi que les huiles contenant des acides gras polyinsaturés comme les huiles d'onagre, de bourrache, de cassis, de germe de blé, et ainsi que des huiles animales comme celles issues du poisson ou des huiles équivalentes. L'indice de peroxydation du groupe des corps gras utilisés est compris entre 70 et 130. In an embodiment of the combination according to the invention, the peroxidized fatty substance (s) are chosen from the group of those which, subjected to x, gamma and beta radiation, during at least the initiation phase of the reaction, comprise a MDA or malmaldehyde level less than 50 ppm. The fatty substances used are more particularly oils. These oils are mostly vegetable. These are generally bodies chosen from the group of ethylenic fatty substances from olive oil, peanut, sesame, corn, sunflower, to which sweet almond oil is added, as well as oils containing polyunsaturated fatty acids such as evening primrose, borage, blackcurrant and wheat germ oils, as well as animal oils such as those obtained from fish or equivalent oils. The peroxidation index of the group of fatty substances used is between 70 and 130.
Suivant les besoins de la formulation, la quantité dans la composition de corps gras peroxydés sera comprise entre 1% et 30% du poids de la formule finie. Depending on the needs of the formulation, the amount in the composition of peroxidized fatty substances will be between 1% and 30% of the weight of the finished formula.
Les actifs végétaux entrant en combinaison dans la composition sont des extraits secs, mous, fluides ou liquides résultant des procédés tels que macération, digestion, décoction, infusion, lixivation, pressage, et par les bio-technologies. The plant active ingredients used in combination in the composition are dry, soft, fluid or liquid extracts resulting from processes such as maceration, digestion, decoction, infusion, leaching, pressing, and by bio-technologies.
L'espèce végétale choisie pour l'invention comprend le groupe des plantes adoucissantes, anti-inflammatoires, antiseptiques, astringentes, calmantes, cicatrisantes, colorantes, décolorantes, détergentes, filmogènes, nutritives, régénérantes, reconstituantes, toniques et absorbantes. The plant species chosen for the invention comprises the group of softening, anti-inflammatory, antiseptic, astringent, calming, healing, coloring, bleaching, detergent, film-forming, nutritious, regenerating, reconstituting, toning and absorbing plants.
L'extrait végétal actif adoucissant est de la saponine de marrons d'Inde..  The active softening plant extract is horse chestnut saponin.
L'actif végétal anti-inflammatoire est de l'extrait de l'harpagophytum de l'Ulmaire ou du chrysantellum, à des doses de 2 à 5%. The anti-inflammatory plant active ingredient is extract of Ulmaire harpagophytum or chrysantellum, at doses of 2 to 5%.
L'actif végétal cicatrisant est un extrait du groupe de plantes comprenant le soucis, l'arnica, la reine des prés, l'huile de pépins de cassis, les phytohormones végétales issues du petit pois ou du houblon. The healing plant active is an extract from the group of plants including marigold, arnica, meadowsweet, blackcurrant seed oil, plant phytohormones from peas or hops.
L'extrait végétal détergent est de la saponine de la
Ficaire.The detergent plant extract is saponin from the
Ficaire.
L'extrait végétal filmogène est pris dans les mucilages de mauve, de fucus ou de tilleul frais, de guimauve, de violettes fraiches. The film-forming plant extract is taken from the mucilages of mauve, fucus or fresh lime, marshmallow, fresh violets.
L'extrait végétal astringent est l'hamamélis. The astringent plant extract is witch hazel.
L'extrait végétal nutritif est choisi dans le groupe des hydrolysats de céréales. The nutritious plant extract is chosen from the group of cereal hydrolysates.
L'extrait végétal régénérant est choisi dans le groupe des phytohormones végétales et des extraits de bourgeons. The regenerating plant extract is chosen from the group of plant phytohormones and bud extracts.
L'extrait végétal reconstituant est choisi dans le groupe des céramides végétales. The reconstituting plant extract is chosen from the group of plant ceramides.
L'extrait végétal antiseptique provient de plantes du groupe comprenant la bardane, l'eucalyptus, la sauge et la
Busserole de 2 Ã 5%. Dans la formule on rajoute des huiles essentielles de 0,1 Ã 0,5%.The plant antiseptic extract comes from plants of the group comprising burdock, eucalyptus, sage and
Compass from 2 to 5%. In the formula we add essential oils from 0.1 to 0.5%.
Parmi les autres associations pouvant être mises en oeuvre, et comme actifs végétaux, les essences de plantes présentent un intérêt, ainsi que les APGI ou acides gras polyinsaturés. Among the other associations that can be implemented, and as plant active agents, plant essences are of interest, as are APGIs or polyunsaturated fatty acids.
La composition cosmétique peut être mise sous la forme d'huile ou d'émulsion ou encore de dispersion. The cosmetic composition can be in the form of an oil or an emulsion or a dispersion.
Des travaux cliniques ont montré le caractère surprenant et donc l'intérêt de l'invention. Clinical studies have shown the surprising nature and therefore the interest of the invention.
Une étude sur le renouvellement cellulaire, par la méthode au DHA (dihydroxyacétone, marqueur colorant des protéines) a été effectuée sur trois groupes de six sujets des deux sexes. Le renouvellement de l'épiderme a été observé en comparant 4 émulsions
La première ne contenant que les excipients ;
La seconde contenant l'huile peroxygénée seule à 5% (huile de maïs) ;
La troisième contenant l'actif végétal seul (3% d'un hydrolysat de soja liquide à 10 grammes par litre et 3% d'un extrait de bourgeons de hêtre liquide à 1 gramme par litre) ; et
La quatrième contient la combinaison selon l'invention, à savoir de l'ordre de 5% d'huile de maïs peroxydée, de l'ordre de 3% d'un hydrolysat de soja liquide à 10 grammes par litre environ et un extrait de bourgeons de hêtre liquide à 1 gramme par litre environ.A cell renewal study using the DHA method (dihydroxyacetone, a protein staining marker) was carried out on three groups of six subjects of both sexes. The renewal of the epidermis was observed by comparing 4 emulsions
The first containing only the excipients;
The second containing 5% peroxygenated oil alone (corn oil);
The third containing the plant active ingredient alone (3% of a liquid soy hydrolyzate at 10 grams per liter and 3% of a liquid beech bud extract at 1 gram per liter); and
The fourth contains the combination according to the invention, namely of the order of 5% of peroxidized corn oil, of the order of 3% of a liquid soy hydrolyzate at approximately 10 grams per liter and an extract of liquid beech buds at around 1 gram per liter.
Une application biquotidienne d'une émulsion différente sur chaque bras est effectuée par les volontaires en répartissant les émulsions afin que chacun soit comparé à un autre chez un même patient. A twice-daily application of a different emulsion on each arm is carried out by the volunteers by distributing the emulsions so that each is compared to another in the same patient.
Au bout de 15 jours, les avant bras des volontaires sont teintés en brun par une pommade à 10% de DHA. After 15 days, the volunteers' forearms are tinted brown with an ointment containing 10% DHA.
L'application des différentes émulsions est poursuivie pendant 15 jours et on procède sur chaque avant bras à des mesures, tous les 2 jours par chromamétrie, de la diminution de coloration de peau. Cette diminution est fonction du renouvellement cellulaire. The application of the various emulsions is continued for 15 days and measurements are taken on each forearm, every 2 days by chromametry, of the decrease in skin color. This decrease is a function of cell renewal.
Dans les conditions de l'étude, l'émulsion selon l'invention contenant l'association huile peroxydée et actif végétal a montré un renouvellement cellulaire augmenté respectivement de 13 et 17% par rapport à l'émulsion contenant l'huile et par rapport à celle contenant l'actif végétal et de 23% par rapport à l'émulsion simple contenant que les excipients. Il en est déduit les mesures de l'augmentation du débit circulatoire. Under the conditions of the study, the emulsion according to the invention containing the peroxidized oil and plant active association showed cell renewal increased by 13 and 17% respectively compared to the emulsion containing the oil and compared to that containing the plant active ingredient and 23% compared to the simple emulsion containing only the excipients. From this the measurements of the increase in circulatory flow are deduced.
Une autre étude, est pratiquée comme indiqué cidessus, avec quatre émulsions différentes, et sur vingt patients afin de mesurer le débit micro-circulatoire. Cette mesure a été réalisée par effet DOPPLER. Another study, is carried out as indicated above, with four different emulsions, and on twenty patients in order to measure the microcirculatory flow. This measurement was carried out using the DOPPLER effect.
La mesure a été pratiquée avant et après l'application des quatre types d'émulsion sur quatre localisations situées au niveau des trochanters. Chaque localisation a servi à l'application d'une émulsion. The measurement was performed before and after the application of the four types of emulsion on four locations located at the level of the trochanters. Each location was used to apply an emulsion.
La seconde mesure est réalisée 15 minutes après l'application des émulsions. Ces mesures ont permis de constater une nette amélioration du débit circulatoire par rapport à la zone ayant reçu l'émulsion simple.The second measurement is carried out 15 minutes after the application of the emulsions. These measurements made it possible to note a marked improvement in the circulatory flow compared to the zone having received the simple emulsion.
L'augmentation est de 22 % pour l'émulsion contenant à la fois l'huile et l'actif, de 15 % pour l'émulsion contenant l'huile et de 9 % pour l'émulsion contenant l'actif végétal.The increase is 22% for the emulsion containing both the oil and the active ingredient, 15% for the emulsion containing the oil and 9% for the emulsion containing the active ingredient.
Une troisième mesure 24 heures après l'application de chaque préparation, montre une perdurance d'un débit circulatoire augmenté d'une proportion de 18% par rapport à la mesure témoin, avec l'association huile peroxygénée/actif végétal. A third measurement 24 hours after the application of each preparation, shows a persistence of a circulatory flow increased by a proportion of 18% compared to the control measurement, with the association of peroxygenated oil / plant active.
Citons des exemples de mise en oeuvre de l'invention.Let us cite examples of implementation of the invention.
Exemple 1 : Formulation d'une pommade pour calmer les rhumatismes, comportant pour 100 grammes - Huile d'arachide peroxydée 10 grammes - Extrait hydroglycolique d'ulmaire 5 grammes - Essences 0,5 gramme - Stéarate mixte de polyglycol 8 grammes - Huile polyoxyéthylénée 3 grammes - Acide palmito stéarique 2 grammes - Acide acrylique réticulée 0,4 gramme - Triéthanolamine 0,6 gramme - Eau et conservateurs QS 70,5 grammes
Exemple 2 : Formulation d'une crème et essais cliniques.Example 1: Formulation of an ointment to calm rheumatism, comprising per 100 grams - Peroxidized peanut oil 10 grams - Hydroglycolic ulmaire extract 5 grams - Essences 0.5 gram - Mixed polyglycol stearate 8 grams - Polyoxyethylenated oil 3 grams - Stearic palmito acid 2 grams - Crosslinked acrylic acid 0.4 gram - Triethanolamine 0.6 gram - Water and QS preservatives 70.5 grams
Example 2: Formulation of a cream and clinical trials.
Cette composition associe un corps gras et deux extraits végétaux - 5 % d'huile de maïs peroxydée - 3 % d'un hydrolysat de soja liquide à 10 grammes par litre - 3 % d'un extrait de bourgeons de hêtre liquide à 1 g par litre
Les excipients, parfums, conservateurs et eau habituels en quantités usuelles.This composition combines a fatty substance and two plant extracts - 5% peroxidized corn oil - 3% of a liquid soy hydrolyzate at 10 grams per liter - 3% of a liquid beech bud extract at 1 g per liter
Usual excipients, perfumes, preservatives and water in usual quantities.
Cette crème a été testée afin d'évaluer en parallèle - L'amélioration de la sécheresse cutanée, et - La diminution de rougeurs d'appuis. This cream has been tested in order to evaluate in parallel - Improvement of skin dryness, and - Reduction of redness of support.
Amélioration de la sécheresse cutanée
Dans 60% des cas, l'application a été jugée satisfaisante et la peau est redevenue lisse et ferme. Improvement of skin dryness
In 60% of cases, the application was deemed satisfactory and the skin became smooth and firm again.
Dans 30% des cas, l'application a été satisfaisante. In 30% of cases, the application was satisfactory.
Dans 8% des cas, elle a été jugée moyennement satisfaisante. In 8% of cases, it was rated as moderately satisfactory.
Enfin dans 2% des cas, elle n'a pas apporté d'effets significatifs. Finally, in 2% of cases, it did not bring any significant effects.
Diminution des rouleurs
Dans 95% des cas de patients présentant une rougeur cutanée, il a été constaté une très nette diminution des rougeurs et une disparition de celles-ci à la poursuite de l'utilisation en 4 à 5 jours.Reduction of rollers
In 95% of cases of patients with redness of the skin, a very marked reduction in redness was observed and disappearance when continued use in 4 to 5 days.
Pour quelques patients un état stationnaire a été constaté. For some patients a stationary state has been observed.
Il a été constaté dans un cas qu'un patient présentant une rougeur depuis 10 jours a vu celle-ci disparaître totalement en une semaine de traitement. It was found in one case that a patient who had had redness for 10 days had seen it disappear completely within a week of treatment.
De très bons résultats ont été observés sur des irritations au niveau des plis inguinaux. Very good results have been observed on irritations in the inguinal folds.
Une telle crème peut s'appliquer sur les épidermes fragilisés par divers stress de nature externe chimique, rayonnements (soleil, brûlure), ou mécanique. Such a cream can be applied to the epidermis weakened by various stresses of an external chemical, radiation (sun, burn), or mechanical nature.
Exemple 3 : Formulation d'un gel antiseptique.Example 3: Formulation of an antiseptic gel.
Aux excipients habituels on ajoute - 10% d'huile de tournesol peroxydée.To the usual excipients is added - 10% peroxidized sunflower oil.
- 2% d'extrait de busserole - 1% d'extrait de sauge - un mélange d'huiles essentielles de lavande et de citron pour 0,2% chacune.- 2% bearberry extract - 1% sage extract - a mixture of lavender and lemon essential oils for 0.2% each.
Ce gel a été testé par la méthode des dilutions en milieu gélosé sur les souches de l'institut Pasteur et on a pu montrer une efficacité bactériostatique. This gel was tested by the method of dilutions in agar medium on the strains of the Pasteur Institute and it was possible to show a bacteriostatic efficacy.
Exemple 4 : Réalisation d'une crème anti-coup en massage pour les sportifs. Example 4: Making an anti-blow massage cream for athletes.
La formulation est analogue à celle de l'exemple 1, les actifs végétaux introduits étant les suivants - Arnica 3% - Huile essentielle de lavande 0,1% - Huile essentielle d'orange 0,1% - Huile essentielle de camphre 0,05%
Cette formule a été testée en milieu sportif.The formulation is analogous to that of Example 1, the plant active agents introduced being the following - Arnica 3% - Lavender essential oil 0.1% - Orange essential oil 0.1% - Camphor essential oil 0.05 %
This formula has been tested in sports.
Exemple 5 : Activité sur les brûlures.Example 5: Activity on burns.
Avec la formulation de l'exemple 2 en prenant comme drogue
Végétale 1% d'extrait de chrysantellum poudre, des essais sur les brûlures ont porté sur des patients en cours de traitement par radiothérapie et présentant des lésions tissulaires importantes dues aux rayonnements.With the formulation of Example 2 taking as a drug
Vegetable 1% extract of chrysantellum powder, burn tests have been carried out on patients undergoing radiotherapy treatment and presenting significant tissue damage due to radiation.
L'application a été pratiquée immédiatement après chaque séance de radiothérapie intense et l'on a procédé à trois applications quotidiennes entre les'séances.The application was made immediately after each intense radiotherapy session and three applications were made daily between sessions.
On a constaté une nette amélioration de la restructuration tissulaire entre les séances et la disparition des lésions cutanées dans les 14 jours suivant l'arrêt du traitement, alors que cette restructuration nécessite sans traitement particulier une durée d'environ 25 à 30 jours.There has been a marked improvement in tissue restructuring between sessions and the disappearance of skin lesions within 14 days of stopping treatment, whereas this restructuring requires approximately 25 to 30 days without specific treatment.
Exemnle 6 : Essai de raccourcissement du temps de cicatrisation.Claim 6: Healing time shortening test.
Avec la formule de l'exemple 2 (ou 5). With the formula of example 2 (or 5).
Cet essai a été réalisé dans un service de grands brûlés et a porté sur 10 patients présentant 20 sites de prélèvements de greffe (2 sites de greffe par patients). This trial was carried out in a burn unit and involved 10 patients with 20 graft sampling sites (2 graft sites per patient).
Chez un même patient, un des sites a reçu un traitement à l'aide de pansements gras, l'autre recevant l'émulsion formulée. Les deux sites de prélèvement étant identiques en profondeur et en surface, la comparaison est objective. In the same patient, one of the sites received treatment with fatty dressings, the other receiving the formulated emulsion. The two sampling sites being identical in depth and on the surface, the comparison is objective.
On a constaté une durée de cicatrisation moyenne pour les pansements gras d'environ 11 jours, alors qu'elle n'a été que de 7 jours pour la préparation. On observe donc un raccourcissement du temps de cicatrisation de 36 %. There was an average healing time for oily dressings of around 11 days, while it was only 7 days for preparation. We therefore observe a shortening of the healing time by 36%.
Exemple 7 : Composition régénérante, avec une formule analogue a celle de l'exemple 2, mais en mettant comme actif végétal des phytohormones végétales extraites du petit pois ou du houblon, à raison de 1 pour mille.Example 7: Regenerating composition, with a formula analogous to that of Example 2, but using plant phytohormones extracted from peas or hops as plant active ingredient, at a rate of 1 per thousand.
Cette formulation est aussi une alternative pour les brûlures, la cicatrisation. Elle convient aussi en cosmétique pour régénérer les tissus. This formulation is also an alternative for burns, scarring. It is also suitable in cosmetics to regenerate tissues.
Claims (22)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9611438A FR2753374B1 (en) | 1996-09-19 | 1996-09-19 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE PLANT EXTRACT, PEROXIDATED VEGETABLE OILS FOR THE SKIN |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9611438A FR2753374B1 (en) | 1996-09-19 | 1996-09-19 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE PLANT EXTRACT, PEROXIDATED VEGETABLE OILS FOR THE SKIN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2753374A1 true FR2753374A1 (en) | 1998-03-20 |
| FR2753374B1 FR2753374B1 (en) | 2000-01-14 |
Family
ID=9495892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9611438A Expired - Lifetime FR2753374B1 (en) | 1996-09-19 | 1996-09-19 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE PLANT EXTRACT, PEROXIDATED VEGETABLE OILS FOR THE SKIN |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2753374B1 (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5980904A (en) * | 1998-11-18 | 1999-11-09 | Amway Corporation | Skin whitening composition containing bearberry extract and a reducing agent |
| EP0968709A1 (en) * | 1998-07-03 | 2000-01-05 | Lanatech Laboratoire Nature et Technique | Cosmetic composition having antiradical synergistic effect |
| EP0900561A4 (en) * | 1997-01-17 | 2000-04-19 | Shiseido Co Ltd | Compositions promoting collagen production |
| EP1002521A1 (en) * | 1998-11-19 | 2000-05-24 | Heilmittelbetrieb Isernhagen GmbH | Use of sage extracts as deodorants |
| EP1051979A1 (en) * | 1999-05-12 | 2000-11-15 | Laboratoire Carilene | Use of peroxidised lipids to prevent and/or treat the irritating effect of an active agent |
| US6395779B1 (en) * | 1999-01-29 | 2002-05-28 | Neoteric Cosmetics, Inc. | Method of treatment using peroxidized lipids |
| DE10114304A1 (en) * | 2001-03-23 | 2002-10-02 | Beiersdorf Ag | Cosmetic and dermatological preparations containing hops or hops-malt extract and use of a hop or hops malt extract for the preparation of cosmetic and dermatological preparations for the reduction of the sebum content of the skin |
| DE10132953A1 (en) * | 2001-07-06 | 2003-01-16 | Beiersdorf Ag | Use of hops or Hop-malt extracts in cosmetic or dermatological preparations for the prophylaxis against and treatment of degenerative skin symptoms |
| US6531165B2 (en) | 1997-01-17 | 2003-03-11 | Shiseido Company, Ltd. | Collagen production promoter composition |
| FR2867071A1 (en) * | 2004-03-02 | 2005-09-09 | Occitane L | Cosmetic or dermatological composition, useful for fighting against the effects of e.g. ageing, cellular hypophyxia and dehydration, comprises olive water concentrated in polyphenols and peroxidized olive oil |
| WO2005092355A1 (en) * | 2004-03-26 | 2005-10-06 | Velez-Rivera Hector | Phyto-composition for the treatment of articular diseases |
| FR2872041A1 (en) * | 2004-06-25 | 2005-12-30 | Maurice Messegue Soc Par Actio | Agent for promoting cutaneous penetration of topically applied cosmetic or pharmaceutical active agents, comprising extract of cells of Ranunculaceae plant, especially lesser celandine |
| WO2006087359A1 (en) * | 2005-02-18 | 2006-08-24 | Pharma Medical Limited | Ozonized composition of animal origin |
| FR2924612A1 (en) * | 2007-12-11 | 2009-06-12 | Nuxe Soc Par Actions Simplifie | Use of poppy petal (Papaver rhoeas) extract to prepare cosmetic and/or dermatological composition e.g. for the nutrition of dermal and epidermal cells, and restructuring and strengthening the dermal and epidermal layers of the skin |
| US8147882B2 (en) | 2009-09-30 | 2012-04-03 | Leonard Lomax | Herbal pain killer compositions |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1176437A (en) * | 1968-02-02 | 1970-01-01 | Berlin Kosmetik Veb | Improvements in or relating to Emulsifiable Oils |
| US4451480A (en) * | 1982-04-16 | 1984-05-29 | James Howard Brown | Method of treating acne using ozonized materials |
| FR2591113A1 (en) * | 1985-12-06 | 1987-06-12 | Desjonqueres Stephane | Massage product for local application, based on natural oil of vegetable origin, intended more especially for sportsmen and -women for preparation of muscles and recovery after exertion |
-
1996
- 1996-09-19 FR FR9611438A patent/FR2753374B1/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1176437A (en) * | 1968-02-02 | 1970-01-01 | Berlin Kosmetik Veb | Improvements in or relating to Emulsifiable Oils |
| US4451480A (en) * | 1982-04-16 | 1984-05-29 | James Howard Brown | Method of treating acne using ozonized materials |
| FR2591113A1 (en) * | 1985-12-06 | 1987-06-12 | Desjonqueres Stephane | Massage product for local application, based on natural oil of vegetable origin, intended more especially for sportsmen and -women for preparation of muscles and recovery after exertion |
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6531165B2 (en) | 1997-01-17 | 2003-03-11 | Shiseido Company, Ltd. | Collagen production promoter composition |
| EP0900561A4 (en) * | 1997-01-17 | 2000-04-19 | Shiseido Co Ltd | Compositions promoting collagen production |
| USRE39043E1 (en) | 1997-01-17 | 2006-03-28 | Shiseido Company, Ltd. | Collagen production promoter composition |
| EP0968709A1 (en) * | 1998-07-03 | 2000-01-05 | Lanatech Laboratoire Nature et Technique | Cosmetic composition having antiradical synergistic effect |
| FR2780647A1 (en) * | 1998-07-03 | 2000-01-07 | Lanatech | COSMETIC COMPOSITION UTILIZING SYNERGISTIC ANTIRADICAL EFFECTS |
| US5980904A (en) * | 1998-11-18 | 1999-11-09 | Amway Corporation | Skin whitening composition containing bearberry extract and a reducing agent |
| EP1002521A1 (en) * | 1998-11-19 | 2000-05-24 | Heilmittelbetrieb Isernhagen GmbH | Use of sage extracts as deodorants |
| US6139825A (en) * | 1998-11-19 | 2000-10-31 | Heilmittelbetreib Isernhagen Gmbh | Use of extracts from sage for producing a deodorizing preparation |
| US6395779B1 (en) * | 1999-01-29 | 2002-05-28 | Neoteric Cosmetics, Inc. | Method of treatment using peroxidized lipids |
| EP1051979A1 (en) * | 1999-05-12 | 2000-11-15 | Laboratoire Carilene | Use of peroxidised lipids to prevent and/or treat the irritating effect of an active agent |
| FR2793410A1 (en) * | 1999-05-12 | 2000-11-17 | Carilene Lab | USE OF PEROXIDE LIPIDS AS AGENTS FOR PREVENTING AND / OR TREATING THE IRRITATING EFFECTS OF AN ACTIVE INGREDIENT |
| US6416767B1 (en) | 1999-05-12 | 2002-07-09 | Laboratoires Carilene | Use of peroxidized lipids as agents intended to prevent and/or to treat the irritant effects of an active principle |
| DE10114304A1 (en) * | 2001-03-23 | 2002-10-02 | Beiersdorf Ag | Cosmetic and dermatological preparations containing hops or hops-malt extract and use of a hop or hops malt extract for the preparation of cosmetic and dermatological preparations for the reduction of the sebum content of the skin |
| DE10132953A1 (en) * | 2001-07-06 | 2003-01-16 | Beiersdorf Ag | Use of hops or Hop-malt extracts in cosmetic or dermatological preparations for the prophylaxis against and treatment of degenerative skin symptoms |
| FR2867071A1 (en) * | 2004-03-02 | 2005-09-09 | Occitane L | Cosmetic or dermatological composition, useful for fighting against the effects of e.g. ageing, cellular hypophyxia and dehydration, comprises olive water concentrated in polyphenols and peroxidized olive oil |
| WO2005092355A1 (en) * | 2004-03-26 | 2005-10-06 | Velez-Rivera Hector | Phyto-composition for the treatment of articular diseases |
| ES2298087A1 (en) * | 2004-03-26 | 2008-05-01 | Hector Velez-Rivera | PHYTO-COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES. |
| ES2298087B1 (en) * | 2004-03-26 | 2009-07-07 | Hector Velez-Rivera | PHYTO-COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES. |
| US7595069B2 (en) | 2004-03-26 | 2009-09-29 | Hector Velez-Rivera | Phyto-composition for the treatment of joint diseases |
| FR2872041A1 (en) * | 2004-06-25 | 2005-12-30 | Maurice Messegue Soc Par Actio | Agent for promoting cutaneous penetration of topically applied cosmetic or pharmaceutical active agents, comprising extract of cells of Ranunculaceae plant, especially lesser celandine |
| WO2006087359A1 (en) * | 2005-02-18 | 2006-08-24 | Pharma Medical Limited | Ozonized composition of animal origin |
| FR2924612A1 (en) * | 2007-12-11 | 2009-06-12 | Nuxe Soc Par Actions Simplifie | Use of poppy petal (Papaver rhoeas) extract to prepare cosmetic and/or dermatological composition e.g. for the nutrition of dermal and epidermal cells, and restructuring and strengthening the dermal and epidermal layers of the skin |
| WO2009101301A3 (en) * | 2007-12-11 | 2009-10-08 | Laboratoire Nuxe | Use of a poppy petal extract for skin nutrition |
| US8147882B2 (en) | 2009-09-30 | 2012-04-03 | Leonard Lomax | Herbal pain killer compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2753374B1 (en) | 2000-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2227977C (en) | Use in a composition of an extract of at least one labiate | |
| EP0624363B1 (en) | Lipid composition for cosmetic products containing unsaturated fatty acid triglycerides | |
| FR2753374A1 (en) | Skin care composition contains peroxidised fatty substance e.g. unsaturated vegetable oils and plant extract | |
| EP0179675B1 (en) | Lipid compositions favouring the growth of phaners, and cosmetic products containing them | |
| EP0771557A1 (en) | Use of ascorbic acid as the actif for the treatment of seborrhea in a cosmetic and/or dermatalogical composition | |
| EP2654762A1 (en) | Extract of the aerial parts of gynandropsis gynandra and cosmetic, dermatoligic and pharmaceutic compositions comprising the extract | |
| EP0655235A1 (en) | Slimming composition | |
| EP3113850B1 (en) | Skin-brightening cosmetic composition | |
| FR2822381A1 (en) | New superoxide dismutase compositions, used for e.g. prevention and treatment allergies, inflammatory disorders, and degenerative disorders, comprise Cucumis melo extract and a liposoluble fatty material | |
| WO2020008151A1 (en) | Oily composition containing an extract of mimosa tenuiflora and uses thereof | |
| FR3135893A1 (en) | use of a polar Skeletonema extract in photodynamic therapy | |
| EP1786384A1 (en) | Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation | |
| EP1887890B1 (en) | Treating keratinous dryness using glycerides | |
| RU2123320C1 (en) | Face cream "talita" | |
| FR2761888A1 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING ANDIROBA EXTRACT | |
| FR2604624A1 (en) | New cosmetic or dermatological compositions that are rich in essential fatty acids present both in the form of triglycerides and in free or salified form | |
| FR2952304A1 (en) | Slimming cosmetic active ingredient, useful to e.g. treat cellulitis and/or appearance of orangey skin, comprises a mixture of a product from Coriandrum sativum fruit and a product from Citrus aurantium dulcis fruit | |
| FR2801789A1 (en) | Compositions comprise keratolin, a lipogenesis inhibitor and excipients for topical application, have a slimming effects on the face | |
| FR3055214A1 (en) | LIGHTENING COSMETIC COMPOSITION | |
| CH689373A5 (en) | Cosmetic moisturising composition | |
| EP0350438B1 (en) | Composition for use in cosmetics or pharmacy | |
| KR101993324B1 (en) | Cosmetic Composition For Improvement of Skin Barrier | |
| CH670951A5 (en) | Cosmetic, cicatrising and disinfectant emulsions - contain vitamin=A ester and hydrogen peroxide | |
| FR2747308A1 (en) | Use of azadirachta indica, hydroxycitrate, ceramides and optionally vitamins or caffeine | |
| FR2681783A1 (en) | Mixture of vegetable oils which is rich in essential fatty acids and its use in cosmetic compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 20 |